Overview

Safety and Efficacy of Two Dosages of Diractin® in Osteoarthritis (OA)

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide replicated evidence of safety and efficacy of 50 mg and 100 mg ketoprofen in Diractin®.
Phase:
Phase 3
Details
Lead Sponsor:
IDEA AG
Treatments:
Celecoxib
Ketoprofen